Recent data regarding the genetics and histopathology of epithelial
ovarian cancer (EOC) has improved our understanding of ovarian
carcinogenesis. These results and current hypotheses indicate that
epithelial ovarian, peritoneal, and tubal cancers are not distinct
entities but represent a spectrum of disease that originates in the
Mulleriancompartment. Due to this new information, the FIGO staging
classification for ovarian, tubal, and peritoneal cancers was revised
(Table 1) [2].
Tubal and peritoneal cancers are now included in the ovarian cancer
staging classification, and the primary site designated when possible [2,3].
This new staging exemplifies our current understanding of the
relationship between these disease entities and challenges our previous
classification of ovarian, peritoneal, and tubal cancers. We and others
assert that this group of gynecologic cancers should becollectively
designated as adenocarcinomas of Mullerian origin. In this review, we
will focus on the incidence, classification, and origin of Mullerian
adenocarcinomas. We will also review the molecular and pathologic
profiling that support the concept of adenocarcinomas of Mullerian
origin as a unified entity and will assist in diagnostic and treatment
paradigms......
Gynecologic Oncology Research and Practice article is worth reading
ReplyDelete